MarketInOut Stock Screener Log In | Sign Up

GC Genome Corp

KRX • Healthcare • Biotechnology • Quote as of 10/30/2026
GC Genome Corp stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeKRX
Market Capitalization197,248 mln
Float12.59 mln

EPS

229
Exceptional

P / E

39.75
Overvalued

Beneish M-Score

-1.87
Caution advised

Relative Strength

71 / 100
Outperforming

Debt / Equity

0.05
Debt-free

Pre-Tax Margin

18%
Healthy margin

Business Description

GC Genome Corporation is a South Korean company founded in 2013 that specializes in genetic testing and analysis across a wide range of medical needs. Its services cover cancer detection, prenatal and newborn screening, rare disease diagnosis, organ transplant monitoring, and personal health insights such as nutrition and biological age. The company also uses artificial intelligence to support early cancer screening and offers tools to help people understand their genetic risk for various conditions.

Key Fundamentals

EPS229
P/E39.75
ROE7.01
RPS1,385
ROIC3.46
ROA6.30
Interest Cover8.46
EBITDA, mln8,794
EV / EBITDA18.94
EV / EBIT27.12
Revenue, mln32,637
EV / Revenue5.10

Quote Details

Last 9,100.00
Change 520 (6.06%)
Open 8,610.00
Volume 2,330,797
Turnover 21,210,253,312
Average Volume 890,839

Financial Ratios

Pre-Tax Profit Margin18
Current Ratio11.82
Price / Book2.56
Price / Tangible Book2.58
Price / Free Cash Flow97.56
Debt / Equity0.05
Price / Sales6.28
PEG Ratio2.26

Financial Strength

Altman Z-Score17.04
Beneish M-Score-1.87
Price to Lynch Fair Value4.73
Price to Graham Number2.08

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -6.19% 21 / 100   
1 Month 3.88% 91 / 100   
2 Months 77.39% 99 / 100   
6 Months 16.07% 96 / 100   
1 Year 27.27% 84 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog